Massachusetts Financial Services’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-365,205
| Closed | -$9.81M | – | 905 |
|
|
2022
Q1 | $9.81M | Buy |
365,205
+10,012
| +3% | +$269K | ﹤0.01% | 636 |
|
|
2021
Q4 | $16.9M | Buy |
355,193
+73,469
| +26% | +$3.5M | ﹤0.01% | 621 |
|
|
2021
Q3 | $18.7M | Sell |
281,724
-3,677
| -1% | -$244K | 0.01% | 620 |
|
|
2021
Q2 | $22.3M | Buy |
285,401
+100,742
| +55% | +$7.86M | 0.01% | 603 |
|
|
2021
Q1 | $17.5M | Sell |
184,659
-4,289
| -2% | -$406K | 0.01% | 614 |
|
|
2020
Q4 | $23M | Buy |
188,948
+67,285
| +55% | +$8.2M | 0.01% | 577 |
|
|
2020
Q3 | $10.6M | Buy |
+121,663
| New | +$10.6M | ﹤0.01% | 626 |
|